WHO ICTRP trial
STUDY OF 26 WEEKS, MULTICENTER, INTERNATIONAL, RANDOMIZED, DOUBLE BLIND, WITH…
PER-044-02 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-044-02 |
|---|---|
| Public title | STUDY OF 26 WEEKS, MULTICENTER, INTERNATIONAL, RANDOMIZED, DOUBLE BLIND, WITH PLACEBO OVERLOAD IN PARALLEL GROUPS, CONTROLLED WITH PLACEBO AND ACTIVE DRUG OF 2 DOSE OF COX189 (200 Y400MG DAILY ONCE A DAY) IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS USING NAPROXENO (500 MG TWICE A DAY) AS AN ACTIVE COMPARATOR. |
| Scientific title | STUDY OF 26 WEEKS, MULTICENTER, INTERNATIONAL, RANDOMIZED, DOUBLE BLIND, WITH PLACEBO OVERLOAD IN PARALLEL GROUPS, CONTROLLED WITH PLACEBO AND ACTIVE DRUG OF 2 DOSE OF COX189 (200 Y400MG DAILY ONCE A DAY) IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS USING NAPROXENO (500 MG TWICE A DAY) AS AN ACTIVE… |
| Primary sponsor | NOVARTIS BIOSCIENSES PERU S.A., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | III |
| Countries | Peru |
| Conditions | -M90 ;M90 |
| Interventions | Group name:400 mg of COX189 Type of group;1 N° of participants:300 Intervention(s) description:COX189 400mg (two tablets of COX189 200mg o.d. + naproxen placebo) Group name:Naproxen 500mg Type of group;2 N° of participants:300… |
| Registration date | May 7, 2002 |
| Target size | 0 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: